Shire halts construction of Cali regenerative medicine plant
Shire has stopped construction on its Californian regenerative medicine site citing adequate capacity in its existing facilities.
Archives for December 11, 2013
Smaller large molecules? Roche invests $62m in DARPin dev deal
Roche has teamed with Molecular Profiles to test if short protein sequences can be used to target conjugated cancer drugs when antibodies prove to large.
AstraZeneca licenses mAb production tech from Lonza and BioWa
AstraZeneca’s biologics division MedImmune has licensed a cell line and antibody production tech from Lonza and BioWa.
Alvotech's $250m Icelandic plant will use disposable tech for mAb biosimilars
Alvogen has branched into biomanufacturing with plans to build a $250m (€182m) facility in Iceland to produce biosimilar monoclonal antibodies.